title: AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism.
authors.forename: M
authors.initials: M
authors.lastname: Romano
mesh_terms: D000574:American Medical Association / Q000191:economics*; D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics*; D004363:Drug Utilization; D004502:Education, Medical, Continuing / Q000191:economics*; D005378:Financial Support; D006801:Humans; D013664:Teaching Materials; D014146:Training Support; D014481:United States